OFI Invest Asset Management Sells 2,563 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

OFI Invest Asset Management trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 123,920 shares of the healthcare conglomerate’s stock after selling 2,563 shares during the quarter. UnitedHealth Group accounts for 1.6% of OFI Invest Asset Management’s holdings, making the stock its 12th largest holding. OFI Invest Asset Management’s holdings in UnitedHealth Group were worth $58,883,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in UNH. True Wealth Design LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at $31,000. Delos Wealth Advisors LLC increased its stake in shares of UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after purchasing an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC purchased a new position in UnitedHealth Group during the second quarter worth approximately $31,000. Signature Resources Capital Management LLC raised its stake in shares of UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 18 shares during the period. Finally, Red Tortoise LLC grew its stake in UnitedHealth Group by 45.1% in the 1st quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock valued at $36,000 after acquiring an additional 23 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently weighed in on UNH shares. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday, August 13th. Truist Financial raised their price target on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. JPMorgan Chase & Co. upped their price target on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. Barclays upped their target price on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. Finally, Robert W. Baird upped their price objective on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $614.17.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded down $1.93 during midday trading on Friday, hitting $577.68. 2,728,939 shares of the company’s stock were exchanged, compared to its average volume of 4,224,914. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $591.54. The stock has a market cap of $533.44 billion, a price-to-earnings ratio of 35.31, a price-to-earnings-growth ratio of 1.61 and a beta of 0.59. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.85 and a current ratio of 0.88. The firm’s 50 day simple moving average is $529.38 and its 200 day simple moving average is $507.45.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter last year, the business earned $6.14 earnings per share. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.45%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.